ORLANDO, Fla., May 12 (UPI) -- Researchers at the Sanford-Burnham Medical Research Institute in Orlando, Florida, have good news for the more than 25 million Americans suffering from asthma: They've discovered a novel molecule that prevents T-cells from coordinating the inflammatory response to allergens. In other words, scientists has found a new substance that quells asthma attacks.
"We have identified a synthetic molecule, a sulfate monosaccharide, that inhibits the signal that recruits T-cells to the lungs to start an asthma attack," confirmed Minoru Fukuda, lead researcher and a professor in the Tumor Microenvironment and Metastasis Program at Sanford-Burnham. "The molecule substantially lessened asthma symptoms such as inflammation, mucus production, and airway constriction."